Rezultati

eNauka >  Results >  BRAF/MEK inhibitor rechallenge in patients with non-resectable or metastatic BRAF V600-mutated melanoma: A stratified, controlled, retrospective EUMelaReg multicenter study
Title: BRAF/MEK inhibitor rechallenge in patients with non-resectable or metastatic BRAF V600-mutated melanoma: A stratified, controlled, retrospective EUMelaReg multicenter study
Authors Weichenthal, Michael; ...; Popovic, Aleksandar; ...; (broj, koautora 31)
Issue Date: 2026
Publication: EJC SKIN CANCER
ISSN: 2772-6118 Search Idenfier
Type: Article
Collation: vol. 4 str. 100776-100776
DOI: 10.1016/j.ejcskn.2026.100776
WoS-ID: 001791987500004
Scopus-ID: 2-s2.0-105027644904
URI: https://enauka.gov.rs/handle/123456789/1046553
Project: Novartis AG, Basel, Switzerland
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

Alt metrika
Dimensions
Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.